Nanoparticles may be key for new pain therapy

The Defense Advanced Research Projects Agency, or DARPA, is funneling $1.3 million to researchers at the University of Michigan to see if they can use nanoparticles to transform the way morphine is used for pain relief on the battlefield. James R. Baker Jr., director of the Michigan Nanotechnology Institute for Medicine and Biological Sciences, said that the university project "uses different medicines coupled to polymers to release drugs and antidotes to provide adequate pain relief while avoiding complications. If successful, it could markedly improve the treatment of soldiers in the field." The therapy would be delivered in a pen-like device that could be employed by anyone, rather than the trained personnel that are needed to dispense morphine. The nanoparticles would be needed to for timed delivery of the drug and for monitoring a patient's breathing so that Naloxone can be released to counter the effects of morphine on breathing.

- read the article on the project from Forbes

Related Articles:
FDA to address nanotech standards. Report
FDA to gather more info on bio-nano. Report
Nanoparticle developed for new drug delivery system. Report
Super-thin membrane advances protein revolution. Report

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.